Medication - Sterile Compounding - Using Primary and Secondary Engineering Controls with Testing/Certification Failures
Can we still use our Primary Engineering Control if it fails its testing/certification ?
Any examples are for illustrative purposes only.
It is up to the organization to determine whether or not the compounding space is acceptable to continue producing sterile compounded medication products. Factors should include the pathogenicity of the organism grown in the positive growth viable sample; complexity level of the compounded product; any known/potential associated hospital acquired infections; and guidance from the infection control practitioner.
It is up to the organization to determine whether or not the compounding space is acceptable to continue producing sterile compounded medication products. Factors should include the pathogenicity of the organism grown in the positive growth viable sample; complexity level of the compounded product; any known/potential associated hospital acquired infections; and guidance from the infection control practitioner.
Manual:
Home Care
Chapter:
Medication Compounding MC
First published date: January 23, 2018
This Standards FAQ was first published on this date.
This page was last updated on October 29, 2021
Useful Resources for Home Care Organizations
Whether you're preparing for an upcoming survey or implementing processes to maintain accreditation compliance, we have the tools and resources you need to succeed.
Go Above and Beyond with Certification
Reduce variation and risk while improving quality care. Certifications from The Joint Commission represent the most stringent, comprehensive and evidence-based proof of the success of your program available.
PolicySource: P&Ps for Compliance with Joint Commission Requirements
Get access to dozens of downloadable, sample policies and procedures required by Joint Commission standards on this easy-to-navigate web-based portal.
Joint Commission Virtual Assistant